key: cord-0696672-r1gpag26
authors: Singh Virk, Jitender; Ali, Syed Azmal; Kaur, Gurjeet
title: Recent update on COVID-19 in India: Is locking down the country enough?
date: 2020-04-10
journal: nan
DOI: 10.1101/2020.04.06.20053124
sha: 90b87bfdea94ee0a26e8b7b9fdf0ac7ba773ba94
doc_id: 696672
cord_uid: r1gpag26

Abstract Background: India is the second-largest population in the world, and it is not well equipped, hitherto, in the scenario of the global pandemic, SARS-CoV-2 could impart a devastating impact on the Indian population. Only way to respond against this critical condition is by practicing large-scale social distancing. India lock down for 21 days, however, till 7 April 2020, SARS-CoV-2 positive cases were growing exponentially, which raises the concerns if the number of reported and actual cases are similar. Methods: We use Lasso Regression with α=0.12 and Polynomial features of degree 2 to predict the growth factor. Also, we predicted Logistic curve using the Prophet Python. Further, using the growth rate to logistic, and carrying capacity is 20000 allowed us to calculate the maximum cases and new cases per day. Results: We found the predicted growth factor with a standard deviation of 0.3443 for the upcoming days. When the growth factor becomes 1.0, which is known as Inflection point, it will be safe to state that the rate is no longer exponential. The estimated time to reach the inflection point is between 15-20 April. At that time, the estimated number of total positive cases will be over 12500, if lockdown remains continue. Conclusions: Our analysis suggests that there is an urgent need to take action to extend the period of lockdown and allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. Otherwise, the outbreak in India can reach the level of the USA or Italy or could be worse than these countries within a few days or weeks, given the size of the population and lack of resources.

. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint 3 Ever since the outbreak of COVID-19, which was initially announced from China's Wuhan city 46 in December 2019 (1). The SARS-CoV-2 virus has affected more than 1,016,401 people in 202 47 countries and territories accounts for a total of 53,160 deaths worldwide, according to the Center 48 for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) and World 49 Health Organization (WHO) (2,3). Therefore, a harmonized global response is desperately 50 needed to prepare health care systems to coincide with this unprecedented challenge. 51 Unfortunately, several countries like China, Italy, Iran, USA, Germany, Spain have been exposed Wuhan region was locked down since mid-January from the rest of the world, and they have not 75 reported any new positive cases for many days. Interestingly, it seems like strict lockdowns 76 appear to have an extraordinary impact on controlling the disease (7). We suggest the Indian government consider fulfilling basic requirements that include food and 90 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint We provide the platform to our political leaders and the government for preparation through 95 forecasting the situation that could happen in upcoming days. It will help them to make adequate 96 measures plus create the appropriate facility accordingly for the COVID-19 infected people.

According to our study and the available data, while China's new cases follow an almost flat 98 curve, other countries such as India, US, Italy, Spain, and Germany still have exponential 99 growth. Particularly to point India's exponential growth followed by Spain and Germany is much 100 worse than Italy besides the number of total cases because of the steep slope of growth rate 101 ( Figure 1 ).

On the other hand, the US is inferior. We kept the frequency of all countries scaled to [0, 1] 103 range only for the trend comparison. As the Indian COVID-19 cases are in exponential growth 104 rate, it is expected that a magnitude of the number of infected cases is coming in the future. The central government of India took the lockdown decision is the crucial step; however, it is 112 hard to say that the lockdown of 21 days is enough. As mentioned above, SARS-CoV-2 infection 113 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint 6 takes around 2-14 days to show its symptoms, and the cases are increasing with new tests on 114 individuals. It raises the concern that how many days these numbers will go up and what quantity 115 of arrangement is required for upcoming days.

Based on the given crowdsourced patient database from 31 January, it is possible to estimate the 118 outcomes of future days and weeks. To predict when the exponential growth will become linear 119 and then flat, we use the growth factor of new cases per day. The

is the number of total positive cases on t day and Once the inflection point is obtained, the further curve will follow the logistic curve, as shown in 130 Figure 4 . After this point, the number of infected cases will still increase, but the rate will no 131 longer be exponential. Eventually, it will become flat then decrease. But, these results 132 correspond to the lockdown. As suggested by Singh and Adhikari (10), the lockdown must CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint 9 It is found that SARS-CoV-2 infection has a more severe impact on older people and individuals 180 with medical history or ongoing conditions such as diabetes, high blood pressure, Cardiovascular 181 disease (CVDs), cancer, or other serious illnesses (12, 13, 14) . In Italy, where more than two-182 thirds of patients died with the mean age of 81 years, reported to be former smokers and 183 suffering from various comorbidities. It clears the fact that having these situations causes acute figure 2 , it is inevitable that India has many more cases 192 to be confirmed as the hospitals will perform more tests in the coming days. Beyond this, it is 193 critical to find how many of them will need intensive care following admission. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint the lockdown data, which is applicable until 14 April 2020. If the lockdown will not extend 203 according to the predicted number of days by (10), without further data, it is difficult to predict 204 the situation. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint 15-20 April. It defines that cases in India will remain constant, and no further addition of new 226 cases will be reported from this point, but keeping this in mind that this point is only possible if 227 lockdown will continue and testing all the possible suspects. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint Figure 3 . Growth factor prediction for present and future: The moving average of the growth factor determined A) Based on the available previous days data . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint

Landscape of COVID-19 candidate vaccines (PDF). WHO

Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures. 274 Emerging infectious diseases

The effect of public health measures on the 1918 influenza 276 pandemic in US cities

Public health interventions and epidemic intensity 279 during the 1918 influenza pandemic

Age-structured impact of social distancing on the COVID-19 282 epidemic in India

Coronavirus in India: Tablighi Jamaat preacher, others booked for violating govt 284 guidelines on religious gatherings

Commentary: COVID-19 in Patients with Diabetes

The cardiovascular burden of coronavirus disease 2019 (COVID-290 19) with a focus on congenital heart disease

author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint

What we know so far: COVID-19 current clinical knowledge and research

Diabetes is India's fastest growing disease: 72 million cases recorded in 2017, figure 295 expected to nearly double by 2025

Tackling the burden of 299 cardiovascular diseases in India: The essential diagnostics list. Circulation: 300 Cardiovascular Quality and Outcomes

author/funder, who has granted medRxiv a license to display the preprint in perpetuity

 243 The authors declare that they have no competing interests CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06. The plateau of the cumulative curve will be reached just over 30 days from March 11, 2020.. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.06.20053124 doi: medRxiv preprint